Salahuddin, S.

indinavir concentration crystallization temperature strength 20 c solution condition 37 plasma body temperature 37 c 6.4 mg /l 20 indinavir crystallization indinavir concentration experiment study value nephron patient solubility room temperature filterable plasma indinavir indinavir plasma concentration tubule indinavir concentrations stone stone formation buffer dosage inhibitor regimen relationship secretion formation henle increase intra-tubular crystallization stock indinavir secretion pharmacokinetic immunodeficiency virus ritonavir protease ph value protease inhibitor range institute stock solution downloaded capacity world countries result 6.4 titration nephron model .3 loops ph increases hiv-infected thai patients oxford university press model-independent data analysis urological side effects ritonavir-boosted regimens .9 van der ende plasma peak concentration load 115 downloaded hiv -1positive patients indinavir stock solution indinavir dosage whilst phmin /phmax range symptom hiv -1+ patients indinavir sulphate powder experiments introduction materials indinavir plasma concentrations filterable interindividual pharmacokinetic differences table ph increases transiently hiv -1-infected patients